You have 9 free searches left this month | for more free features.

rituximab

Showing 2326 - 2350 of 2,665

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Lymphoma Trial in New York (filgrastim, rituximab, cyclophosphamide)

Completed
  • Leukemia
  • Lymphoma
  • filgrastim
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 24, 2013

Follicular Lymphoma Trial in Saint Louis (Combination of treatment modalities)

Completed
  • Follicular Lymphoma
  • Combination of treatment modalities
  • Saint Louis, Missouri
    Saint Louis University Cancer Center
May 9, 2014

Non-Hodgkin's Lymphoma, Lymphoma, Large Cell, Diffuse, Mantle Cell Lymphoma, Lymphoma Trial in Japan, Korea, Republic of (SyB

Completed
  • Non-Hodgkin's Lymphoma
  • +4 more
  • SyB L-0501
  • Rituximab
  • Nagoya, Aichi, Japan
  • +24 more
May 29, 2013

B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013

Burkitt Lymphoma, Non-Hodgkins Lymphoma, Atypical Burkitt Lymphoma Trial in Boston (Rituximab, Cyclophosphamide, Doxorubicin)

Terminated
  • Burkitt Lymphoma
  • +2 more
  • Rituximab
  • +9 more
  • Boston, Massachusetts
  • +1 more
Apr 17, 2013

Rheumatoid Arthritis Trial (methotrexate, rituximab, corticosteroids)

Completed
  • Rheumatoid Arthritis
  • (no location specified)
May 7, 2013

Thrombotic Thrombocytopenic Purpura Trial in United States (Rituximab, Plasma exchange, Corticosteroids)

Terminated
  • Thrombotic Thrombocytopenic Purpura
  • Rituximab
  • +2 more
  • Birmingham, Alabama
  • +22 more
Jul 18, 2013

Lymphoma Trial in Houston (Etoposide, G-CSF, GM-CSF)

Completed
  • Lymphoma
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Jun 3, 2013

Breast Cancer Trial in Beijing (Wire-localized abnormal node)

Completed
  • Breast Cancer
  • Wire-localized abnormal node
  • Beijing, China
    Breast cancer, Peking University Cancer Hospital & Institute
Jun 16, 2014

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus (bendamustine HCl, obatoclax

Withdrawn
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +6 more
  • bendamustine hydrochloride
  • +2 more
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Jun 5, 2013

Hemophilia A Trial in United States (Rituximab)

Completed
  • Hemophilia A
  • Rituximab
  • Orange, California
  • +12 more
Jun 7, 2013

Metastatic Melanoma Trial in Vienna (rituximab)

Terminated
  • Metastatic Melanoma
  • rituximab
  • Vienna, Austria
    General Hospital Vienna, Dep. of Dermatology, Division of Immuno
Apr 24, 2013

Myeloma, Lymphoma Trial in Atlanta (Plerixafor)

Completed
  • Myeloma
  • Lymphoma
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Sep 16, 2014

Focal Segmental Glomerulosclerosis, Steroid Resistant Nephrotic Syndrome Trial in Washington DC (D-Galactose)

Completed
  • Focal Segmental Glomerulosclerosis
  • Steroid Resistant Nephrotic Syndrome
  • Washington DC, District of Columbia
    Children's National Medical Center
Sep 8, 2014

Non Hodgkin's Follicular Lymphoma Trial in Modena (Bortezomib (VELCADE), Rituximab)

Completed
  • Non Hodgkin's Follicular Lymphoma
  • Bortezomib (VELCADE)
  • Rituximab
  • Modena, Italy
    Gruppo Italiano Studio Linfomi
Apr 11, 2013

Indolent Non Hodgkin Lymphoma Trial in Modena (Lenalidomide, Rituximab)

Unknown status
  • Indolent Non Hodgkin Lymphoma
  • Modena, MO, Italy
    Centro Oncologico Modenese
Apr 9, 2013

Bullous Pemphigoid Trial in Durham (Rituximab)

Completed
  • Bullous Pemphigoid
  • Rituximab
  • Durham, North Carolina
    Duke University Medical Center
Apr 9, 2013

Squamous Cell Carcinoma Trial in Chicago (Cetuximab and Lenalidomide)

Completed
  • Squamous Cell Carcinoma
  • Cetuximab and Lenalidomide
  • Chicago, Illinois
    The University of Chicago
Nov 17, 2014

Chronic Lymphocytic Leukemia Trial run by the NCI (biological, drug, other)

Completed
  • Chronic Lymphocytic Leukemia
  • Rituximab
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 19, 2013

Chronic Focal Encephalitis, Rasmussen's Encephalitis Trial in San Francisco (Rituximab)

Completed
  • Chronic Focal Encephalitis
  • Rasmussen's Encephalitis
  • Rituximab
  • San Francisco, California
    California Pacific Medical Center
Mar 20, 2013

Immune Thrombocytopenic Purpura Trial in Monterrey (Rituximab and dexamethasone)

Completed
  • Immune Thrombocytopenic Purpura
  • Rituximab and dexamethasone
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr. Jose E Gonzalez UANL
Mar 21, 2013

Lymphoma Trial in Puerto Rico, South Africa, United States (rituximab)

Completed
  • Lymphoma
  • rituximab
  • Scottsdale, Arizona
  • +68 more
Aug 14, 2013

Malignant Melanoma of Skin Stage III, Metastatic Melanoma Trial in Encinitas (Rituxan)

Unknown status
  • Malignant Melanoma of Skin Stage III
  • Metastatic Melanoma
  • Encinitas, California
    California Cancer Associates For Research,cCARE
May 16, 2014

Leukemia, Lymphoma, Lymphoproliferative Disorder Trial in New York (beta-glucan, rituximab)

Terminated
  • Leukemia
  • +2 more
  • beta-glucan
  • rituximab
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Mar 18, 2013

Lymphoma, Leukemia Trial in Houston (Zevalin Radioimmunotherapy, Rituximab, Fludarabine)

Completed
  • Lymphoma
  • Leukemia
  • Zevalin Radioimmunotherapy
  • +4 more
  • Houston, Texas
    MD Anderson Cancer Center
Jun 11, 2013